These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 8643223)

  • 1. Response of brain metastases from lung cancer to systemic chemotherapy with carboplatin and etoposide.
    Malacarne P; Santini A; Maestri A
    Oncology; 1996; 53(3):210-3. PubMed ID: 8643223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-platinum chemotherapy combined with etoposide in metastatic brain tumor from small cell lung carcinoma.
    Yamada SM; Yamada S; Takahashi H; Teramoto A; Nakayama H
    J Neurooncol; 2005 Feb; 71(3):259-65. PubMed ID: 15735914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of ifosfamide, carboplatin, and oral etoposide chemotherapy for extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group pilot study.
    Wolff AC; Ettinger DS; Neuberg D; Comis RL; Ruckdeschel JC; Bonomi PD; Johnson DH
    J Clin Oncol; 1995 Jul; 13(7):1615-22. PubMed ID: 7602350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I and pharmacologic study of sequential topotecan, carboplatin, and etoposide.
    Miller AA; Niell HB
    Lung Cancer; 2001; 33(2-3):241-8. PubMed ID: 11551419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Front-line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, nonsmall cell lung carcinoma, or malignant melanoma: a prospective study.
    Franciosi V; Cocconi G; Michiara M; Di Costanzo F; Fosser V; Tonato M; Carlini P; Boni C; Di Sarra S
    Cancer; 1999 Apr; 85(7):1599-605. PubMed ID: 10193952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase I trial defining the maximum tolerated systemic exposure of topotecan in combination with Carboplatin and Etoposide in extensive stage small cell lung cancer.
    Gillenwater HH; McCune JS; Lindley C; Faucette S; Shord S; Donahue A; Socinski MA; Stewart CF; Zamboni WC; Kirstein MN; Moore D
    Cancer Invest; 2005; 23(6):511-9. PubMed ID: 16203659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lung cancer with bone metastasis].
    Katakami N
    Gan To Kagaku Ryoho; 2006 Aug; 33(8):1049-53. PubMed ID: 16912519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of temozolomide with other cytotoxic chemotherapy in the treatment of patients with recurrent brain metastases from lung cancer.
    Ebert BL; Niemierko E; Shaffer K; Salgia R
    Oncologist; 2003; 8(1):69-75. PubMed ID: 12604733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of ifosfamide in combination with carboplatin and etoposide in small cell lung cancer.
    Lee HS; Lee YG; Koo DH; Oh S; Nam H; Song JU; Lim SY; Lim SY; Lee SS
    Cancer Chemother Pharmacol; 2015 Nov; 76(5):933-7. PubMed ID: 26374553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ifosfamide-based chemotherapy for previously treated lung cancer patients.
    Chen YM; Liu JM; Wu MF; Wu HW; Lin WC; Tsai CM; Perng RP; Whang-Peng J
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Jul; 61(7):389-96. PubMed ID: 9699391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer: update and preliminary survival analysis.
    Strauss GM; Lynch TJ; Elias AD; Jacobs C; Herbst R; Leong T; Lynch C; Kwiatkowski DJ; Carey RW; Grossbard ML; Skarin AT
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-73-S12-80. PubMed ID: 9331127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral etoposide and carboplatin. Effective therapy for elderly patients with small cell lung cancer.
    Evans WK; Radwi A; Tomiak E; Logan DM; Martins H; Stewart DJ; Goss G; Maroun JA; Dahrouge S
    Am J Clin Oncol; 1995 Apr; 18(2):149-55. PubMed ID: 7534977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First line chemotherapy in patients with brain metastases from non-small and small cell lung cancer.
    Tummarello D; Lippe P; Bracci R; Mari D; Monterubbianesi MC; Battelli N
    Oncol Rep; 1998; 5(4):897-900. PubMed ID: 9625841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
    Lee YC; McCrystal MR; Christmas TI
    N Z Med J; 1998 Nov; 111(1078):451-2, 453-4. PubMed ID: 9891564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel, carboplatin, and oral etoposide in the treatment of small cell lung cancer.
    Greco FA; Hainsworth JD
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):7-10. PubMed ID: 9007113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel and carboplatin in the treatment of small-cell lung cancer patients resistant to cyclophosphamide, doxorubicin, and etoposide: a non-cross-resistant schedule.
    Groen HJ; Fokkema E; Biesma B; Kwa B; van Putten JW; Postmus PE; Smit EF
    J Clin Oncol; 1999 Mar; 17(3):927-32. PubMed ID: 10071286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is carboplatin and oral etoposide an effective and feasible regimen in patients with small cell lung cancer?
    Pfeiffer P; Sørensen P; Rose C
    Eur J Cancer; 1995; 31A(1):64-9. PubMed ID: 7695981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carboplatin in combination with etoposide in inoperable non-small-cell lung cancer (NSCLC).
    Weynants P; Humblet Y; Bosly A; Schallier D; Duprez P; Majois F; Beauduin M; Prignot J; Symann M
    Med Oncol Tumor Pharmacother; 1990; 7(4):219-22. PubMed ID: 2178205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current standards of care in small-cell and non-small-cell lung cancer.
    Schiller JH
    Oncology; 2001; 61 Suppl 1():3-13. PubMed ID: 11598409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination chemotherapy with carboplatin, etoposide, and vincristine as first-line treatment in small-cell lung cancer.
    Gatzemeier U; Hossfeld DK; Neuhauss R; Reck M; Achterrath W; Lenaz L
    J Clin Oncol; 1992 May; 10(5):818-23. PubMed ID: 1314891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.